• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, July 15, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Study Finds Smokers Rarely Increase Smoking After Switching to Low-Nicotine Cigarettes

Bioengineer by Bioengineer
July 15, 2026
in Chemistry
Reading Time: 2 mins read
0
Study Finds Smokers Rarely Increase Smoking After Switching to Low-Nicotine Cigarettes
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

WINSTON-SALEM, N.C., July 15, 2026 — A new systematic review suggests that switching to cigarettes engineered with dramatically reduced nicotine is unlikely to trigger the kind of “behavioral compensation” that regulators fear. Published in JAMA Network Open, the study—led by researchers at Wake Forest University School of Medicine—finds little evidence that smokers increase cigarette consumption or smoke more intensely to recover nicotine delivery.

The review pooled results from 17 randomized clinical trials including more than 5,500 adolescents and adults. Across study designs, participants did not reliably escalate smoking to counteract nicotine reduction. Instead, many smokers reported or were observed to smoke fewer cigarettes after switching to very low nicotine products.

The findings are especially relevant to a proposed U.S. Food and Drug Administration product standard that would reduce nicotine levels in cigarettes and certain other combusted tobacco products to minimally or nonaddictive levels. Although the rule remains under FDA review, the core regulatory question is whether nicotine reduction would be undermined by compensatory changes in smoking behavior over time.

Lead author Rachel Denlinger-Apte, Ph.D., M.P.H., explains that this matters because nicotine is the addictive chemical driving tobacco dependence. Lowering nicotine may therefore help prevent new generations from becoming addicted and could also ease quitting by reducing withdrawal-related motivation.

A persistent concern has been confusion between truly low-nicotine cigarettes and older “light” cigarette designs. “Light” products are not meaningfully nicotine-reduced; they typically dilute smoke using ventilated filters, a strategy linked in past eras to compensatory smoking—such as taking more puffs or inhaling more deeply.

In contrast, the new evidence indicates that nicotine-lowered cigarettes do not replicate that compensation pattern. Across trials, none reported increases in the average number of cigarettes smoked per day among participants assigned to very low nicotine cigarettes.

Sixteen of 17 trials also found decreases in cigarettes per day relative to traditional cigarette conditions. Several studies additionally documented spontaneous quit attempts, suggesting that nicotine reduction may not only fail to provoke overuse, but may coincide with reduced dependence-driven smoking.

The review further reports no evidence of increases in carbon monoxide exposure, a common proxy for smoke uptake. After six weeks, fewer than 1% of participants were predicted to smoke more, reinforcing the overall conclusion that widespread compensation is unlikely.

Overall, the analysis strengthens the scientific rationale for nicotine product regulation. Tobacco use remains a major cause of preventable death, even as cigarette smoking rates fall, and policymakers are seeking tools that reduce addiction while supporting cessation.

Subject of Research: People
Article Title: Compensatory Smoking With Very Low Nicotine Content Cigarettes
News Publication Date: 15-Jul-2026
Web References: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2026.22543
References: 10.1001/jamanetworkopen.2026.22543
Image Credits:

Tags: adolescent smoking habitsbehavioral compensation in smokersclinical trials on smokingFDA tobacco regulationimpact of nicotine reductionlow-nicotine cigarettesnicotine reduction regulationpublic health implications of nicotine reductionsmoking behavior changesmoking intensity and frequencysystematic review of smoking studiestobacco dependence prevention

Share12Tweet7Share2ShareShareShare1

Related Posts

ROS Dynamics Controlled by Polyoxometalate-Functionalized Fe3O4 Nanozyme for Infected Wound Healing

ROS Dynamics Controlled by Polyoxometalate-Functionalized Fe3O4 Nanozyme for Infected Wound Healing

July 15, 2026

Researchers Say Solar Storm Risks May Be Underestimated

July 15, 2026

Cross-Scale Intelligence Framework Enables Predictions for Aquatic Ecosystem Health

July 15, 2026

Rapid Mass Spectrometry Maps Traditional Chinese Medicine Beyond the Laboratory

July 15, 2026

POPULAR NEWS

  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15
  • A varied menu

    51 shares
    Share 22 Tweet 12
  • 研究人员开发认知工具包,实现阿尔茨海默症早期检测

    50 shares
    Share 20 Tweet 13
  • Porcine Heart Transplant

    50 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Self-Aligned Heterogeneous Integration Advances Quantum Photonics Fabrication

Local Complement C3 Shapes Control Myeloid Infiltration and Checkpoint Blockade Efficacy

Longitudinal Urine Metabolomics Predicts High-Grade Brain Injury in Very Preterm Infants

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.